Placebo + paclitaxel + carboplatin

DRUG2 trials

Sponsors

Bayer, Mateon Therapeutics

Conditions

Anaplastic Thyroid CancerCarcinoma, Non-Small-Cell Lung

Phase 3

A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)

TerminatedNCT00558636

BayerCarcinoma, Non-Small-Cell Lung

Start: 2007-09-30End: 2008-05-31Updated: 2013-12-27

Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer

WithdrawnNCT01701349

Mateon TherapeuticsAnaplastic Thyroid Cancer

Start: 2015-03-31End: 2017-12-31Updated: 2014-05-01